Macro- and micronutrients in metabolic (dysfunction) associated fatty liver disease: association between advanced fibrosis and high dietary intake of cholesterol/saturated fatty acids.

Guveli H., Kenger E. B., Ozlu T., Kaya E., Yilmaz Y.

European journal of gastroenterology & hepatology, vol.33, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 33
  • Publication Date: 2021
  • Doi Number: 10.1097/meg.0000000000002110
  • Journal Name: European journal of gastroenterology & hepatology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Keywords: fibrosis, metabolic (dysfunction) associated fatty liver disease, nutrition, screening, TRANSIENT ELASTOGRAPHY, HEPATIC-FIBROSIS, NAFLD, FRUCTOSE
  • Recep Tayyip Erdoğan University Affiliated: No


Background and aim There is still no approved pharmacotherapy for metabolic (dysfunction) associated fatty liver disease (MAFLD). Although dietary and lifestyle modifications for weight loss remain the mainstay for disease management, the association between macro- and micronutrients and fibrosis stage in patients with MAFLD remains unclear. This study was undertaken to address this issue.